| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Sruti Shiva | |
| Sergey Zharikov | |||
| P2860 | cites work | Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease | Q24294639 |
| Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation | Q29614475 | ||
| Mitochondria: in sickness and in health | Q29614825 | ||
| Origin and functional consequences of the complex I defect in Parkinson's disease | Q30469425 | ||
| Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease | Q33220863 | ||
| Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes | Q33341223 | ||
| Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes | Q33371694 | ||
| Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease | Q33836235 | ||
| Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes | Q34103846 | ||
| Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A--activation and long-term commitment to cell death | Q34921671 | ||
| Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis | Q35561214 | ||
| Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis | Q36407225 | ||
| Transmitochondrial technology in animal cells | Q36796270 | ||
| Apoptosis in the anucleate platelet | Q37953023 | ||
| Blood platelet biochemistry | Q37961396 | ||
| Platelets and primary haemostasis | Q37969498 | ||
| Simultaneous measurement of aggregation, secretion, oxygen uptake, proton production, and intracellular metabolites in the same platelet suspension | Q39295930 | ||
| Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents | Q39939559 | ||
| Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease | Q41015571 | ||
| Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study | Q42508975 | ||
| Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential | Q43260146 | ||
| Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction | Q43618967 | ||
| Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation | Q44247278 | ||
| Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. | Q44535339 | ||
| Thrombin generation: phenotypic quantitation | Q44783380 | ||
| Pathologic high shear stress induces apoptosis events in human platelets | Q44953566 | ||
| Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease | Q45294442 | ||
| Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease | Q46691979 | ||
| Platelet mitochondrial evaluation during cytochrome c and dichloroacetate treatments of MELAS. | Q46806159 | ||
| Neuroleptic medications inhibit complex I of the electron transport chain | Q48298621 | ||
| Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease | Q48595004 | ||
| Mitochondrial alterations in Alzheimer's disease. | Q50798874 | ||
| A model for the stoichiometric regulation of blood coagulation. | Q52044713 | ||
| Carbohydrate metabolism in human platelets in a low glucose medium under aerobic conditions. | Q52293645 | ||
| Cytochrome oxidase deficiency in Alzheimer's disease. | Q53181028 | ||
| Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. | Q53546960 | ||
| Thrombin-triggered platelet apoptosis. | Q53600485 | ||
| Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. | Q53920138 | ||
| Ueber einen neuen Formbestandtheil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung | Q54107892 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| biomarker | Q864574 | ||
| P304 | page(s) | 118-123 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Biochemical Society Transactions | Q864226 |
| P1476 | title | Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease | |
| P478 | volume | 41 |
| Q89598491 | A Pilot Study on the Effects of l-Carnitine and Trimethylamine-N-Oxide on Platelet Mitochondrial DNA Methylation and CVD Biomarkers in Aged Women |
| Q47646403 | A Useful Device to Measure Kinetics of Platelet Contraction. |
| Q35308828 | A novel model for studies of blood-mediated long-term responses to cellular transplants |
| Q90221144 | A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets |
| Q37541024 | A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers |
| Q43235803 | An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia. |
| Q39899975 | Bioenergetic profiling of platelet mitochondria during storage: 4°C storage extends platelet mitochondrial function and viability |
| Q91795773 | Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine |
| Q37302239 | Blood cell respirometry is associated with skeletal and cardiac muscle bioenergetics: Implications for a minimally invasive biomarker of mitochondrial health |
| Q42331828 | Blood-based bioenergetic profiling: A readout of systemic bioenergetic capacity that is related to differences in body composition |
| Q41291477 | Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome |
| Q41254414 | Comparison of intraplatelet reactive oxygen species, mitochondrial damage, and platelet apoptosis after implantation of three continuous flow left ventricular assist devices: HeartMate II, Jarvik 2000, and HeartWare |
| Q47585916 | Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study |
| Q47896131 | Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR-/- mice. |
| Q35190154 | Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function |
| Q27318101 | Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer |
| Q92340252 | Emergence of AnnexinVpos CD31neg CD42blow/neg extracellular vesicles in plasma of humans at extreme altitude |
| Q37096976 | Ex vivo apoptotic and autophagic influence of an estradiol analogue on platelets. |
| Q91965859 | Exercise Training Enhances Platelet Mitochondrial Bioenergetics in Stroke Patients: A Randomized Controlled Trial |
| Q89149591 | Exposure to hypoglycemia and risk of stroke |
| Q41444067 | Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets. |
| Q33830008 | High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic Stress |
| Q34486294 | Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients |
| Q28392567 | How Parkinsonian toxins dysregulate the autophagy machinery |
| Q37558180 | Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury |
| Q39016705 | Identification of a new Mpl-interacting protein, Atp5d |
| Q35971929 | Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. |
| Q41251598 | Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils |
| Q58611546 | Mitochondria as a therapeutic target for common pathologies |
| Q33954232 | Mitochondria in monocytes and macrophages-implications for translational and basic research |
| Q64111113 | Mitochondria in precision medicine; linking bioenergetics and metabolomics in platelets |
| Q33553590 | Mitochondrial changes in platelets are not related to those in skeletal muscle during human septic shock |
| Q58611349 | Novel Lines of Evidence for the Asymmetric Strand Displacement Model of Mitochondrial DNA Replication |
| Q97523765 | Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis |
| Q92921857 | Peripheral Blood Mononuclear Cells and Platelets Mitochondrial Dysfunction, Oxidative Stress, and Circulating mtDNA in Cardiovascular Diseases |
| Q91028697 | Physiology of cold-stored platelets |
| Q90632991 | Platelet Mitochondrial Respiration, Endogenous Coenzyme Q10 and Oxidative Stress in Patients with Chronic Kidney Disease |
| Q88177943 | Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research |
| Q89746482 | Platelet mitochondrial DNA methylation predicts future cardiovascular outcome in adults with overweight and obesity |
| Q47424665 | Platelet mitochondrial dysfunction and the correlation with human diseases |
| Q38681139 | Platelet storage performance is consistent by donor: a pilot study comparing "good" and "poor" storing platelets. |
| Q38485691 | Polyphosphate: A Morphogenetically Active Implant Material Serving as Metabolic Fuel for Bone Regeneration |
| Q26768208 | Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment |
| Q59799935 | Potential role of platelets for atherosclerotic events in rheumatoid arthritis |
| Q28394996 | Redox biology and the interface between bioenergetics, autophagy and circadian control of metabolism |
| Q49025509 | Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro. |
| Q58111649 | Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model |
| Q100526045 | Simvastatin improves mitochondrial respiration in peripheral blood cells |
| Q41193811 | Single Cell Oxygen Mapping (SCOM) by Scanning Electrochemical Microscopy Uncovers Heterogeneous Intracellular Oxygen Consumption. |
| Q28074178 | Skeletal muscle mitochondrial health and spinal cord injury |
| Q36207736 | Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets |
| Q35842168 | Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential |
| Q34368877 | The Bioenergetic Health Index: a new concept in mitochondrial translational research |
| Q91805812 | The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function |
Search more.